Cosmo Robotics, a wearable robot specialist (CEO Jooyoung Oh), announced on the 21st that its youth recycling robot 'BAMBINI' recently received medical device certification from the China Food and Drug Administration (CFDA).
This is a double whammy, following last year’s CFDA certification of Cosmo Robotics’ adult robot (EA2), and the first time in the wearable robot industry that two types of robots have received Chinese certification.
China has already emerged as the world's largest consumer market for wearable robots. Therefore, Bambini's CFDA certification is evaluated as a stepping stone for securing additional markets in China and improving CosmoRobotics' status.
Cosmo Robotics has its own sales corporations in the US, Japan, Europe, Russia, and China, and plans to further accelerate its entry into overseas markets through these corporations.
Cosmo Robotics, an affiliate of Cosmo Group, which owns two listed companies, Cosmo Chemical and Cosmo New Materials, is preparing for a KOSDAQ listing in the first half of this year as a technology special case. NH Investment & Securities is currently the lead manager for Cosmo Robotics’ listing.
This company focuses on developing intelligent wearable rehabilitation robots and industrial robots. In particular, it supplies rehabilitation robots that can be used for all types of disabilities throughout the life cycle, including infants, adolescents, and the elderly, both domestically and internationally. Its current main products include the ground-walking robot 'EA2 Pro', the children's walking rehabilitation robot 'Bambini Teens', and the industrial wearable robot 'EXA-W', and it is currently developing robots for various fields.
- See more related articles
You must be logged in to post a comment.